Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.22.2.2
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue:        
Total revenue $ (438) $ 181 $ (418) $ 568
Operating expenses:        
Cost of goods sold 2,368 199 2,791 620
Selling, general and administrative 7,683 10,438 29,003 28,351
Research and development 5,266 3,404 14,816 9,489
Total operating expenses 15,317 14,041 46,610 38,460
Loss from operations (15,755) (13,860) (47,028) (37,892)
Other income (expense):        
Change in fair value of warrant liability 651 1 651 6
Other income, net 65 51 174 127
Interest income 127 39 246 130
Interest expense (401)   (726)  
Loss on foreign currency exchange 18 (2) 18 (6)
Total other income (expense), net 460 89 363 257
Net Loss (15,295) (13,771) (46,665) (37,635)
Other comprehensive loss        
Unrealized gain (loss) on marketable securities 32   (28)  
Comprehensive loss $ (15,263) $ (13,771) $ (46,693) $ (37,635)
Per share information:        
Net loss per share of common stock, basic (in dollars per share) $ (0.09) $ (0.08) $ (0.28) $ (0.23)
Net loss per share of common stock, diluted (in dollars per share) $ (0.09) $ (0.08) $ (0.28) $ (0.23)
Weighted average common shares outstanding, basic (in shares) 170,725,392 164,510,570 167,276,563 162,811,136
Weighted average common shares outstanding, diluted (in shares) 170,725,392 164,510,570 167,276,563 162,811,136
Product revenue        
Revenue:        
Total revenue $ (438) $ 112 $ (438) $ 499
License revenue        
Revenue:        
Total revenue   $ 69 $ 20 $ 69